The Chinese Biopharmaceutical Association (CBA-US), one of the largest Chinese professional associations in the US, will hold its 20th annual conference in China on June 26-30 this year. 

 

The conference consists of two parts. The pre-conference will start at the historical Hefei city, Anhui Province, sponsored by the Peking Universitys SinoBioway Group, and the Hefei Municipal Government on June 26-28. And then the main conference will be held in the beautiful coastal city LianYunGang of Jiangsu Province, sponsored by the Overseas Chinese Affairs Office of the Jiangsu Provincial Government and the LianYunGang Municipal Government, on June 29-30.

The theme of the 20th CBA Annual Conference is “Globalization of Biopharmaceutical Development and Commercialization - Emerging Markets Opportunities”. This theme has been carefully selected to address the critical importance of emerging markets (e.g. China) in biopharmaceutical innovation and worldwide collaboration to capture the great opportunity for the advancement of modern medicine and biopharmaceuticals. Plenary and Keynote sessions will be presented by world renowned scientists (Nobel Price Award winner and members of US and Chinese Academy of Sciences) and executives from multinational pharmaceutical companies. These distinguished speakers will address the audience on the industry trends and some of the most exciting discovery and advancement in Biopharmaceutical, Novel therapeutic drug Development. The conference will cover many different aspects of biopharmaceutical development and commercialization especially opportunities and challenges in emerging markets.

 

Applitech pharmaceutical equipment technology co., LTD, will fully support this meeting as a platinum sponsor, wishing  the conference a complete success.